CN1205988C - Medicine for treating hepatitis - Google Patents
Medicine for treating hepatitis Download PDFInfo
- Publication number
- CN1205988C CN1205988C CN 03125194 CN03125194A CN1205988C CN 1205988 C CN1205988 C CN 1205988C CN 03125194 CN03125194 CN 03125194 CN 03125194 A CN03125194 A CN 03125194A CN 1205988 C CN1205988 C CN 1205988C
- Authority
- CN
- China
- Prior art keywords
- medicine
- parts
- hepatitis
- present
- sophorae flavescentis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses medicine for treating hepatitis, which is Chinese patent medicine prepared by using silibinin, gardenia, capillary artemisia, 15 of red sage root, lightyellow sophora root and amur corktree bark as raw materials according to the conventional preparation technology. The present invention is medicine which is prepared according to new medicine proportion. The present invention adopts Chinese medicinal materials which are familiar in countries as the raw materials, so the cost is low. The medicine has the functions of improving liver function and liver cell membrane and has the characteristics of simple manufacture, low cost and good therapeutic effect, which can be used for treating acute hepatitis, chronic hepatitis and persistent hepatitis.
Description
Technical field: the present invention relates to a kind of Chinese medicine preparation, particularly a kind of Chinese patent medicine for the treatment of the hepatitis disease.
Background technology: at present, the medicine of treatment hepatitis disease is more, and various medicines have the characteristics of oneself separately, but also have certain deficiency simultaneously, so various medicine can and be deposited on market, and is accepted by the patient.
Summary of the invention: the objective of the invention is to, a kind of medicine of new treatment hepatitis disease is provided.The effect that improves liver function and liver plasma membrane is arranged, can be used for the treatment of acute, chronic hepatitis and chronic persistent hepatitis.
Technical scheme of the present invention.A kind of medicine for the treatment of the hepatitis disease, it is with the following materials of weight proportions Chinese patent medicine that is prepared into of preparation process routinely:
30～60 parts of 0.66～1.3 portion of Fructus Gardeniaes of silymarin
10～20 parts of 10～20 parts of Radix Salviae Miltiorrhizaes of Herba Artemisiae Scopariae
20～40 parts of 30～60 portions of Cortex Phellodendris of Radix Sophorae Flavescentis.
The medicine of above-mentioned treatment hepatitis disease, the better weight proportion of each raw material is:
40～50 parts of 0.8～1.1 portion of Fructus Gardeniaes of silymarin
13～18 parts of 13～18 parts of Radix Salviae Miltiorrhizaes of Herba Artemisiae Scopariae
25～35 parts of 40～50 portions of Cortex Phellodendris of Radix Sophorae Flavescentis.
The medicine of aforesaid treatment hepatitis disease, the better weight proportion of each raw material is:
44～46 parts of 0.9～1 portion of Fructus Gardeniaes of silymarin
14～16 parts of 14～16 parts of Radix Salviae Miltiorrhizaes of Herba Artemisiae Scopariae
29～31 parts of 44～46 portions of Cortex Phellodendris of Radix Sophorae Flavescentis.
Compared with the prior art, the present invention is a kind of medicine of making by new component and proportioning.It adopts comparatively in the localities Chinese medicinal herbses of seeing as raw material more, and is with low cost.This medicine has the effect that improves liver function and liver plasma membrane.Have the making of being easy to, cost is lower, the characteristics that therapeutic effect is good.Can be used for the treatment of acute, chronic hepatitis and chronic persistent hepatitis.
The specific embodiment:
Embodiment 1.Water intaking flies silibin 1Kg, Fructus Gardeniae 45Kg, Herba Artemisiae Scopariae 15Kg, Radix Salviae Miltiorrhizae 15Kg, Radix Sophorae Flavescentis 45Kg, Cortex Phellodendri 30Kg are raw material.Manufacture method by capsule is made capsule.By every 0.5 gram, every day three times, each 4.
Embodiment 1.Water intaking flies silibin 1Kg, Fructus Gardeniae 45Kg, Herba Artemisiae Scopariae 15Kg, Radix Salviae Miltiorrhizae 15Kg, Radix Sophorae Flavescentis 45Kg, Cortex Phellodendri 30Kg are raw material.Manufacture method by capsule is made capsule.By every 0.5 gram, every day three times, each 4.
Embodiment 2.Water intaking flies silibin 0.8Kg, Fructus Gardeniae 48Kg, Herba Artemisiae Scopariae 13Kg, Radix Salviae Miltiorrhizae 14Kg, Radix Sophorae Flavescentis 49Kg, Cortex Phellodendri 26Kg are raw material.Manufacture method by capsule is made capsule.By every 0.5 gram, every day three times, each 4.
Embodiment 3.Water intaking flies silibin 1.1Kg, Fructus Gardeniae 40Kg, Herba Artemisiae Scopariae 18Kg, Radix Salviae Miltiorrhizae 17Kg, Radix Sophorae Flavescentis 42Kg, Cortex Phellodendri 33Kg are raw material.Manufacture method by capsule is made capsule.By every 0.5 gram, every day three times, each 4.
The present invention also routinely preparation process be prepared into other dosage forms such as tablet, electuary, syrup.
Claims (3)
1, a kind of medicine for the treatment of the hepatitis disease is characterized in that, it is with the following materials of weight proportions Chinese patent medicine that is prepared into of preparation process routinely:
30～60 parts of 0.66～1.3 portion of Fructus Gardeniaes of silymarin
10～20 parts of 10～20 parts of Radix Salviae Miltiorrhizaes of Herba Artemisiae Scopariae
20～40 parts of 30～60 portions of Cortex Phellodendris of Radix Sophorae Flavescentis.
2, the medicine of treatment hepatitis disease according to claim 1 is characterized in that, the weight proportion of each raw material is:
40～50 parts of 0.8～1.1 portion of Fructus Gardeniaes of silymarin
13～18 parts of 13～18 parts of Radix Salviae Miltiorrhizaes of Herba Artemisiae Scopariae
25～35 parts of 40～50 portions of Cortex Phellodendris of Radix Sophorae Flavescentis.
3, the medicine of treatment hepatitis disease according to claim 2 is characterized in that, the weight proportion of each raw material is:
44～46 parts of 0.9～1 portion of Fructus Gardeniaes of silymarin
14～16 parts of 14～16 parts of Radix Salviae Miltiorrhizaes of Herba Artemisiae Scopariae
29～31 parts of 44～46 portions of Cortex Phellodendris of Radix Sophorae Flavescentis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03125194 CN1205988C (en) | 2002-12-06 | 2003-05-13 | Medicine for treating hepatitis |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN02127997 | 2002-12-06 | ||
| CN02127997.7 | 2002-12-06 | ||
| CN 03125194 CN1205988C (en) | 2002-12-06 | 2003-05-13 | Medicine for treating hepatitis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1466984A CN1466984A (en) | 2004-01-14 |
| CN1205988C true CN1205988C (en) | 2005-06-15 |
Family
ID=34195398
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 03125194 Expired - Lifetime CN1205988C (en) | 2002-12-06 | 2003-05-13 | Medicine for treating hepatitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1205988C (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1977887B (en) * | 2005-12-05 | 2011-02-09 | 山东轩竹医药科技有限公司 | Medicinal composition for treating hepatitis |
| CN1981833B (en) * | 2005-12-05 | 2011-05-18 | 山东轩竹医药科技有限公司 | Medicinal composition of elutriate, virgate wormwood herb and and cape-jasmine |
-
2003
- 2003-05-13 CN CN 03125194 patent/CN1205988C/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CN1466984A (en) | 2004-01-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1057451C (en) | Children coryza medicine and preparing method | |
| CN101028481A (en) | Medicinal liquor for treating hyperosteogeny and lumbar intervertebral disc protrusion | |
| CN1201782C (en) | Medicine composition for treating mammary gland proliferation, and its prepn. method | |
| CN1205988C (en) | Medicine for treating hepatitis | |
| CN1147314C (en) | Medicine for treating gynecopathy | |
| CN1895646A (en) | Chinese medicine for treating diabetes mellitus and its preparation | |
| CN1058640C (en) | Magnetic medicine plaster and its making method | |
| CN1336212A (en) | Diabetes treating medicine | |
| CN1182858C (en) | Heart-nourishing tea capsule and its prepn | |
| CN1698863A (en) | Chinese medicinal preparation for treating hyperosteogeny | |
| CN1385203A (en) | Compound Chinese medicine preparation of damnacanthus | |
| CN1308020C (en) | Traditional Chinese medicine composition for treating psoriasis | |
| CN1255149C (en) | Combination of medication | |
| CN1739736A (en) | Medicine prepn for treating nodules of breast | |
| CN1051926C (en) | Anti-cancer Chinese drug-Xiaoliujing capsule | |
| CN1289129C (en) | Chinese herbal medicine for treating hepatitis | |
| CN1186063C (en) | Medicine for treating diabetes and its complication | |
| CN1864737A (en) | Powder dedicated for treating leukemia and preparation method thereof | |
| CN1086949C (en) | Chinese medicine for hepatitis B and its preparation | |
| CN1257709A (en) | Chinese medicine | |
| CN1129578A (en) | Formulation of Ganmaosuyusan for curing common cold | |
| CN1596961A (en) | Chinese patent drug dispersing tablet for treating gynecologic inflammation and its preparation method | |
| CN1342492A (en) | Medicine for treating eczema, seborrheic dermatitis and acne | |
| CN1162470A (en) | Chinese medicine for chronic rhinitis and the preparation method | |
| CN102078521A (en) | Medicament for treating hepatitis B and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: SHENQI PHAMACEUTICAL CO LTD, GUIZHOU Free format text: FORMER OWNER: SHENQI PHARMACEUTICAL FACTORY, GUIZHOU PROV. Effective date: 20120330 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 550001 GUIYANG, GUIZHOU PROVINCE TO: 550004 GUIYANG, GUIZHOU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20120330 Address after: 550004 Guizhou Province, Guiyang city Beijing Road No. 1 Patentee after: GUIZHOU SHENQI PHARMACEUTICAL Co.,Ltd. Address before: 550001 No. 1, Gui Gui Road, Guizhou, Guiyang, China Patentee before: Guizhou Shenqi Pharmaceutical Co.,Ltd. |
|
| C56 | Change in the name or address of the patentee |
Owner name: GUIZHOU SHENQI PHARMACEUTICAL CO., LTD. Free format text: FORMER NAME: SHENQI PHAMACEUTICAL CO LTD, GUIZHOU |
|
| CP01 | Change in the name or title of a patent holder |
Address after: 550004 Guizhou Province, Guiyang city Beijing Road No. 1 Patentee after: GUIZHOU SHENQI PHARMACEUTICAL Co.,Ltd. Address before: 550004 Guizhou Province, Guiyang city Beijing Road No. 1 Patentee before: GUIZHOU SHENQI PHARMACEUTICAL Co.,Ltd. |
|
| CX01 | Expiry of patent term |
Granted publication date: 20050615 |
|
| CX01 | Expiry of patent term |